Seeking Alpha


Send Message
View as an RSS Feed
View matty0454's Comments BY TICKER:
Latest  |  Highest rated
  • General Moly - The Times They Are A-Changin' [View article]
    I would love to see this company get the financing to get it's mine open. Unfortunately, GMO the poster child for what is wrong with business in this country today. Ready to mine, but can't get even a hint of help from its own state or federal government (especially the most worthless Senator- Harry Reid). Always lots of talk about job producing, "shovel-ready" jobs, etc., but never any action to help.
    Jun 10, 2014. 12:22 PM | 6 Likes Like |Link to Comment
  • Senators introduce regenerative medicine bill [View news story]
    About time something like this has happened.long overdue legislation.
    Mar 14, 2014. 04:28 PM | 2 Likes Like |Link to Comment
  • Recent Developments Do Not Justify Athersys' Doubling Since December [View article]
    Seriously? That is the best you have- that you are contrarian to those who have researched, done due diligence, and followed the ATHX story for a long time? Those submitting comments here aren't doing so because they are looking for a battle. The comments are to protest such an appalling presentation that flies in the face of the company's development and progress. You, sir, should really be embarrassed by both your weak article, and your even weaker responses. The announcements that the company will make in the next few months will further add to your lack of credibility.
    Feb 26, 2014. 07:22 AM | 5 Likes Like |Link to Comment
  • Neuralstem, StemCells, Inc., And Athersys, Inc. - Making Early Headlines In 2014 [View article]
    Sir: Very interesting piece. Thanks for putting it together. As a side comment, you mention in your next to last paragraph that Neuralstem is looking forward to Phase 2 results in April. The same is true of Athersys, as the top line data for the company's Phase 2 trials for UC are currently being analyzed ans scheduled for release in April/May. This should give a real indication of the potential of Multistem as a treatment in this area. I will look forward to your future publications.
    Jan 24, 2014. 01:00 PM | 3 Likes Like |Link to Comment
  • Athersys: Why Did Shareholders Come Knocking At The Door Once Again? [View article]
    Jan 17, 2014. 12:31 PM | Likes Like |Link to Comment
  • Athersys: Why Did Shareholders Come Knocking At The Door Once Again? [View article]
    BioTexGuy: I just spent the last half hour looking at SABBY's 13G filings regarding Athersys, but am not skilled in reading these. Please interpret what these mean. Thanks in advance.
    Jan 15, 2014. 08:31 PM | 1 Like Like |Link to Comment
  • Prognosticating 2014: Athersys Shares Will Continue To Climb [View article] $3.50 today this has doubled in less than a month. time to think about getting a name change. shouldnstart with something like toostupidto...
    Jan 8, 2014. 11:25 AM | 2 Likes Like |Link to Comment
  • Athersys, Inc.: Clinical Trial For Inflammatory Bowel Disease [View article]
    Dandi: I don't mean to answer for Uncle Bud, but click on the "Comments (2)" by Uncle Bud's name above his post. I think his only other post answers your question. He is "in deep".... like some of the rest of us.
    Jul 23, 2013. 08:31 PM | Likes Like |Link to Comment
  • Does Cell Therapy Hold The Key To Treating Stroke? [View article]
    Jason: Really great piece. Thanks for the research you have done and the science you have presented in your article.

    The only place that I disagree with you is in your response above. One of the sale points of the "off-the-shelf" use of MultiStem is that is can be frozen and stored for five years (not sure where I read this, but have seen it multiple times). While I agree that hospitals may not stockpile this in mass quantities, I do believe that most hospitals and regional stroke trauma centers will stock this as they do other drugs and therapeutic agents. Every hospital, even in rural settings, see many stroke cases annually, and of course, the metropolitan centers see multiple cases daily. The ability to store MultiStem for an extended period will be one of its greatest attributes.

    Thank you again for the extensive research and work you put into this piece. Best wishes.
    May 13, 2013. 04:28 PM | 1 Like Like |Link to Comment
  • StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company [View article]
    Hey, great! You going to pump this one too, and then trash it in a couple of weeks like you did Athersys? Same format you used with them... phoney!
    May 2, 2013. 08:30 AM | 7 Likes Like |Link to Comment
  • Athersys, Inc: The Facts [View article]
    Outstanding! Very thorough, based on science, citing mulitple sources...THIS piece shows the essence of Athersys. Thank you!
    Apr 20, 2013. 03:31 PM | 5 Likes Like |Link to Comment
  • Trading Athersys: Risks And Rewards [View article]
    Forget it. Irresponsible article that completely destroys your credibility. You write a month ago about the positives of ATHX and its upside, then take a 180 degree spin, when nothing negative has happened (unless you don't believe peer reviewed articles). And don't play the "do my very best in exploring both upside and down side".. you were either shorting or looking to buy lower...either way, it shows a complete lack of integrity. Take accountability for your trash- if this were paper, I would use it to wipe mysself.

    If "MAD" magazine still is published, go write for them...they are more in line with your style
    Apr 19, 2013. 06:28 PM | 1 Like Like |Link to Comment
  • Trading Athersys: Risks And Rewards [View article]
    Zack's still rating it as a #1. Presentation this week was positive. There is no science in your foolish piece at all. You, sir, are a disgrace. I hope this piece warrants some kind of legal action, as it is simply libel.
    Apr 19, 2013. 12:38 PM | 6 Likes Like |Link to Comment
  • Athersys, Inc. Has Blockbuster Potential [View article]
    Excellent synopsis of this potentially great company. For both your own information, and for any others who follow this, I have attached links to the IC and Stroke trials as filed with the National Institute of Health. These have a little more technical information, but also include tentative dates for trial results.
    Mar 27, 2013. 07:45 PM | Likes Like |Link to Comment
  • A Candid Conversation With Athersys CEO Gil Van Bokkelen [View article]
    Congratulations to you, sir, on a great two-part piece. I have owned the stock for a number of years, and have yet to see anything to confirm my faith in this company and its potential as the articles you have written in the past two days. I am sure there is still a need for patience, but it is apparent that once this company gets an approval, this thing is going to go up exponentially. Thank you for your thorough work. Just plain awesome!
    Jan 31, 2013. 01:57 PM | Likes Like |Link to Comment